chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I21.4 ACUTE NON ST ELEVATION MI 4/4/2023 ADULT OBSTRUCTIVE SLEEP APNEA, MODERATE J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/4/2023 ADULT OBSTRUCTIVE SLEEP APNEA, MODERATE I21.4 ACUTE NON ST ELEVATION MI 4/4/2023 ACUTE NON ST ELEVATION MI J96.11 CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/4/2023 ACUTE NON ST ELEVATION MI
pt had diarrhea x 1 wk p/vax, fever & runny nose; seen by MD 27FEB95 dx as virus; no tx; On 6MAR95 had staring episodes & lethargic x 12 hr w/fever around 100F:
Migraine (not responsive to medicines), dizziness, chest pain, tachycardia, shortness of breath, back pain.
Local injection site erythema, myalgia, headache with elevated intracranial pressure.
This spontaneous report as received from a nurse refers to a 14 year old patient of an unknown gender. On 03-MAR-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
The vial was good until 07/25/2021 @10:11 a.m. however, the vaccine was administered past the allotted time.  Therefore, it was considered expired
after 10 min of vaccination pt reported to employee than she is feeling tingling sensation on both sides of the her mouth employee ask if pt need the epipen shot pt say no, she just want to get benadryl.  50mg benadryl was given to pt in the vaccine room and a bottle of water was given to pt.  After was 10 minutes pt stated that she is feeling better.  Employee continue to tell pt to wait another 15 minutes before she leaves.
A non-serious spontaneous report of administered of expired product was received from a health professional concerning an 11-year-old male patient. Neither relevant medical history nor concomitant medications have been reported for this patient. The product expired on 06-Dec-2010. The patient received the expired FLUMIST on 09-Dec-2010. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
Arm had been very sore after Prevnar 13 vaccination, more than a usual vaccination.  But on 8/16, entire upper arm was becoming warm and itchy.  On 8/17, two large red patches appeared (each approx 4" across) on the upper arm.  The lower patch also had a large knot that was movable.  Both patches became very itchy. Contacted and was seen by family phys on 8/18, who felt it was hives and started on steroid dose pack and two antihistamines.
A week after injection at injection site itching and a circular raised swelling about 2 inches at diameter.  No pain or soreness but intermittent itchiness.
Information has been received from a physician concerning a 19 year old female patient with a history of papilloma virus infection (HPV) and no drug reaction or allergies who on 07-APR-2011 was vaccinated IM with a first 0.5ml dose of GARDASIL (lot # 666987/1016Z, exp date 22-NOV-2011). There was no concomitant medication. The patient had no HPV lesions present at the time of vaccination and the following day, on 08-APR-2011, the patient felt sore in the vaginal area. The lesions found were consistent with HPV. The patient was treated with ALDARA 5% cream. No laboratory diagnostics studies performed. At the time of reporting, the patient was recovering. The patient sought medical attention by phone call and office visit. No further information is available.
headache, congestion, nonproductive cough, chills, shortness of breath (mild, hx of asthma, has been using albuterol which has been helpful), body aches, loss of taste, loss of smell, diarrhea, ear pain, post nasal drainage. starting 12/30/21
Persistent dizziness,  unable to look up without almost falling backwards.   Lasted for over a year.   ENT physician helped
No adverse effects reported.; a patient, 53 years old, inadvertently received a dose of PROQUAD.; This spontaneous report was received from a nurse referring to a 53 years old male patient. Information about pertinent medical history, concurrent conditions and drug reactions/allergies was not provided. The patient's vaccination history was unknown. The patient's concomitant therapy included sterile diluent.   On 30-MAY-2019, the patient was inadvertently vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) 0.5 milliliter(ml) (lot #S002495 with expiration date 23-JUL-2020; strength was not reported) subcutaneously for prophylaxis (adult use of a child product). No adverse effects was reported. The outcome of the event was unknown. The causality of the event was not provided.
Felt tired; Back hurts; Pop in neck and back; Pop in neck and back; Headache; Cramps, sometimes in his legs and hands; Feels weak sometimes; Has a little bit of pain in his chest; Body hurt, reclarified, joints hurt; This is a spontaneous report from a contactable male consumer reported for himself. A 62-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: unknown, Expiration date: unknown), via unspecified route, on 03May2021 (at the age of 62-year-old) as 2nd dose, single dose for COVID-19 immunization. Patient previously received the first dose of BNT162B2 vaccine on an unspecified date (lot/batch and expiry date unknown). The patient medical history and concomitant medications were not reported. On 03May2021, after the vaccination, the first day patient felt tiredness, later (unspecified date in May2021) the patient explained his body hurt- reclarified as joints hurt, back hurts, pop in his neck and back, headache, cramps sometimes his legs and hands, feels weak sometimes, little bit of pain in his chest. Caller stated he has waited for his effects to go away, but it has been a month. Caller stated his body hurt, reclarified as joints hurt, and it was not going away (not recovered). The outcome of the other events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
pt recv vax & devel fever to 104 & diarrhea following the vax;both infants were dx w/rotavirus infect;treating MD does not believe these events were r/t vax;
Shortly after receiving the influenza vaccine the patient briefly fainted while sitting outside the vaccination area in a chair. After regaining consciousness, the patient briefly felt nauseous. The patient declined needing emergency services. The patient's mother was present at the time and took the patient home when she felt better. Patient was instructed to seek medical care if her condition worsened. Patient was contacted the day after the vaccination and was feeling much better.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Medium
Pink, blotchy color on left arm (arm the shot was given in) lasted a week. Arm cramps in left arm. Headaches that last a week. Nauseous.
Vertigo which I am still experiencing almost 3 weeks after first dose.; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 05Apr2021 at 15:15 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021, the patient had vertigo and was still experiencing at the time of reporting almost 3 weeks after the first dose. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vertigo and was still experiencing almost 3 weeks after first dose was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
positive test for she have corona virus; positive test for she have corona virus; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Pfizer product), dose 2 via an unspecified route of administration on 07May2021 as single dose for COVID-19 immunisation. The patient historical vaccine included first dose of BNT162B2 for Covid-19 immunization. The patient concomitant medications were not reported. As reported, the patient experienced 'She just received a positive test for she have corona virus right now she received the positive test for the virus test' on 20Jul2021. As reporter stated, his wife just received a positive test for she had corona virus right at that time. She received the positive test for the virus test. He just, want to get first the concern, if the quality of the vaccine, and happened accidents with corona virus and he guess if they can start quarantine, what should he do about that." Reporter stated, "I haven't been tested yet, but I am about to". The test that she got that day was a swab test and it was a rapid test on 20Jul2021. He asked was it possible that a false positive test occur after she received the vaccine." The patient lab data included rapid test for corona virus with results of positive on 20Jul2021. The outcome of the events was unknown.    The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow up.
Breakthrough COVID-19 infection. Asymptomatic patient tested due to routine screening for discharge. Positive test collected 08/19/2022.
Patient had rash on her trunk and legs. There was no rash at injection site. Patient had severe itching all over.
PATIENT EXPERIENCING DECREASED RANGE OF MOTION OF THE LEFT ARM/SHOULDER WITH MILD TENDERNESS AT THE INSERTION SITE OF LEFT DELTOID; ABLE TO LIFT LEFT ARM 100 DEGREE ONLY. PATIENT HAVING SEVERE LEFT SHOULDER PAIN.
The night after my vaccination I had pain in my ears and had a headache as well as fatigue and overall not feeling well.  By April 8th my symptoms we greatly reduced.  My vaccination spot remained red and wam for the retainer of that week.  I have had a headache since April 13,  2021.  On April 24th I noticed a rash the softball size at my injection site that included lots of red dots all around.  There was also warmth in the rash area.  I went to unspecified pharmacy with my headaches and rash.   Due to my symptoms I was referred to emergency department.
Cold and Flu like symptoms, memory difficulty, failure and loss memory, short term memory loss, mood angry, neck rigid, pain neck and sleep problem.
within several minutes of receiving Moderna, pt c/o coughing spells and SOB, no angioedema or hives.  Self-adminstered albuterol neb she had brought with at 3:30.  Some improvement, benadryl 50mg given at 3:38.  Pt initially  continued to improve and was monitored.  At 3:48 writer entered the room to find pt bent over stating "I can't breath", was pale.  Epipen administered.  Within minutes pt had improved, breathing easier, lungs clear, there was never any oral swelling.  EMS arrived and transported pt to ER.  of note, pt was given red liquid benadryl as it was all we had;  she stated she had a history of sensitivity to red dye but not anaphylaxis,  just will "feel sick" the next day
Rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     Concurrent medical conditions included Kidney stones and Thyroid nodule.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced RASH (Rash). At the time of the report, RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Had severely rapid heart rate and trouble breathing for 48 hours post second Covid vaccination.  Heart rate was so rapid that I thought that I was having a heart attack.  Also had 103 fever, headache, and general malaise.
Cellulitis; A spontaneous report was received from a 75-year-old female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and developed cellulitis.   The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, included levothyroxine, clopidogrel, rosuvastatin, vitamin D, and zinc.   On 14 Jan 2021, approximately one week prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (Lot number: 041L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 21 Jan 2021, the patient developed cellulitis.   On 24 Jan 2021, the patient was seen in urgent care and given antibiotics for the cellulitis infection.   Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the event, cellulitis, was unknown.; Reporter's Comments: This spontaneous report concerns a 75-year-old female patient on blood thinners who experienced a serious event of cellulitis approximately 1 week after the administration of the first dose of the mRNA-1273 vaccine (Lot #: 041L20A, expiration date-Unknown).  Treatment given include an unspecified antibiotic, and outcome is unknown.  Based on the information provided, which includes a temporal association between the reported event and the administration of mRNA-1273 vaccine, a causal association cannot be excluded. Causality is confounded by the patient's advanced age.
This spontaneous report as received from a health professional refers to a 4 year old patient. On 16-MAY-2014 the patient was vaccinated with (Oka/Merck) VARIVAX lot # J012377, expiration date 03-OCT-2015, dose and route not reported) and MMR II (lot # J013315, expiration date 18-OCT-2015, dose and route not reported) which were stored improperly. There was no adverse effect reported. This is one of several reports received from the same source. Additional information is not expected.
Fever highest it got was 102 stayed @ 100.8 for 24 hours, nausea, chills, headache, loss of appetite
3 hrs after vaccine, intense pain throughout arm, especially shoulder to elbow, prohibiting  lifting or movement of arm in any direction. Intensity continued for approx 20 hours & then began to lessen.  No sleep, pain pills used with no relief.   Milder pain still present after 72 hrs, mostly in shoulder.  Day after vaccine,  nausea present & attempt at eating resulted in throwing up food.  This continued for 24 hours.   NO redness, swelling, or even a mark where vaccine administered.
Patient presents today with complaints of probably shingles under her right axilla area extending inward over the right breast somewhat as well as around to the upper portion of the back along the bra line.  She started with pain in the area about 3 days after receiving her 2nd Covid Vaccine and the rash developed a few days after that. Terribly painful and she is finding it hard to be comfortable.  She is having issues sleeping due to the discomfort.   She has no fever. No other symptoms.  Wounds do not appear infected.
Initial report received from a consumer on 24 September 2012. A 42-year-old female patient with no medical history and concomitant medications had received FLUZONE (batch number UT4475AA) through intradermal route in the right deltoid region on 20 September 2012. At the time of vaccination on 20 September 2012, the patient had difficulty breathing, felt hot and was "shakey". The patient's whole arm became hot and a red area developed at the injection site. She experienced warm feeling throughout her body, felt like she was going to get sick to her stomach and vomit. She now felt like that she was coming down with the flu and her muscles and joints ache and just doesn't feel well. Laboratory investigations and corrective treatment was not reported. The patient was not recovered from the events; at the time of report. Documents held by sender: None. Follow-up information received on 19 November 2012. Details of patient address was updated. As of on 19 November 2012, it was reported that the patient was had hard time breathing and the patient was sick for 10 days after vaccination. Documents held by sender: none.
About three weeks after first shot my heart was racing, I was getting dizzy then suddenly felt like my heart stopped. I Hit myself in the chest and it went back into rhythm. I called Dr. office assuming it was the Wolff-Parkinson-White syndrome again but the appointment took so long and I started to feel fine so I cancelled it. Then I got my next shot on 4-8-21 and by approx. 4/29/21 I had another episode made another appointment it took so long and I felt a little better so I cancelled. Then I got the last booster on 11/02/2021 I had another really bad incident where I almost went unconscious while driving so I made another appointment and did not cancel again I was assuming that my Wolff-Parkinson-White was coming back and starting to wonder if it was the Covid-19 shot!  Each incident occurred just weeks after the shot! Dr. put me on a heart monitor for 30 days and at the appointment advised that the Covid-19 shot was the culprit and that my heart was now enlarged and I have to take medicine and be monitored
cold sore on her bottom lip; This case was reported by a consumer via call center representative and described the occurrence of cold sores lip in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included cancer.   On 9th November 2019, the patient received the 1st dose of Shingrix. In December 2019, 1 month after receiving Shingrix, the patient experienced cold sores lip. On an unknown date, the outcome of the cold sores lip was unknown.   It was unknown if the reporter considered the cold sores lip to be related to Shingrix.  Additional details was provided as follows: The age at vaccination was not reported. The patient experienced a cold sore on her bottom lip about 1 month later after receiving 1st dose of Shingrix. Consent to follow up was denied.
15 year old male here with grandmother due to concerns regarding chest pain and shortness of breath.  Received the 2nd dose of Pfizer vaccine 4 days ago.  That evening had body aches, chills, fever and shortness of breath. The other symptoms resolved the next day, but continues with shortness of breath, worsening over time.  This morning, associated with some mid sternal chest pain.  Was able to rake grass outside yesterday, but reports made SOB worse.  History of asthma, reports symptoms not typical of usual exacerbation, has trialed Albuterol without relief.  Denies dizziness, palpitations.   15 year old male with post vaccine associated myocarditis. Troponin I  0.426 ng/mL (<0.300)  H*  06/28/2021  01:24
Initial and follow up information has been received from a health professional concerning a 68 year old white female, with hypertension, hypercholesterolemia, penicillin allergy, venous insufficiency and peripheral vascular disorder who on 08-NOV-2005 was vaccinated intramuscularly in the left deltoid with a second dose  (0.5 ml) of pneumococcal 23v polysaccharide vaccine (lot 651329/1047P) and at the same time was vaccinated intramuscularly in the right deltoid with a second dose of influenza virus SAg 3v vaccine inactivated (CHIRON). On 08-NOV-2005 the patient's left deltoid area became red, swollen, warm to touch and sore.  The patient was notified to use warm compresses and call back if no better.  Subsequently, on an unknown date, the patient recovered.  No product quality complaint was involved.  Additional information is not expected.
pt recvd vax 22SEP94 & 23SEP94 pt in sick call w/either a fever &/or systemic rxn;sxs resolved p/several days;
terrible pain; can hardly lift her arm; low grade fever 98.7 F; extreme pain in her joints; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (terrible pain), VACCINATION SITE MOVEMENT IMPAIRMENT (can hardly lift her arm), PYREXIA (low grade fever 98.7 F) and ARTHRALGIA (extreme pain in her joints) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (terrible pain), VACCINATION SITE MOVEMENT IMPAIRMENT (can hardly lift her arm), PYREXIA (low grade fever 98.7 F) and ARTHRALGIA (extreme pain in her joints). At the time of the report, VACCINATION SITE PAIN (terrible pain), VACCINATION SITE MOVEMENT IMPAIRMENT (can hardly lift her arm), PYREXIA (low grade fever 98.7 F) and ARTHRALGIA (extreme pain in her joints) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not reported by the reporter. Treatment details were not reported by the reporter.
Vaccine had expiration date of April 17, 2022 Given on  May 31, 2022  No adverse event only expired medication.
nausea; chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea) and CHILLS (chills) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Not Provided) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NAUSEA (nausea) and CHILLS (chills). At the time of the report, NAUSEA (nausea) and CHILLS (chills) outcome was unknown.            No concomitant medication details were reported. No Treatment Medications were reported.
Vaccine was administered after a temperature excursion of an unknown amount of time but may have exceeded 36 hours room temperature (~72 hours would be the maximum time at room temperature). There was a failure in our temperature monitoring system to alert staff regarding the temperature excursion.
This case was reported by a pharmacist via sales rep and described the occurrence of pain in arm in a female patient who received SHINGRIX. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than year after receiving SHINGRIX, the patient experienced pain in arm and mobility decreased. On an unknown date, the outcome of the pain in arm and mobility decreased were recovered/resolved. It was unknown if the reporter considered the pain in arm and mobility decreased to be related to SHINGRIX. Additional details were provided as follows: This case was the reported by pharmacist who herself received the SHINGRIX vaccine. The age at vaccination was not reported. The patient experienced a sore arm that she could not lift for 36 hours after the first injection of SHINGRIX. This case was linked to the case US2018GSK047404, reported for the same patient and also US2018GSK047403, reported by the same reporter for different patient.
With the 1st dose: sore arm for a few days and slight fever 12 hours after shot  With 2nd dose: headache, nausea, chills and slightly sore arm 12 hours after shot.  24 hours after injection, fever of 102°-103°, headache, chills and slight sore throat feeling. Fever lasted until around 2AM on Friday (approx 36 after injection). Woke up Friday with pronounced metallic taste in mouth. By 4:00pm, metallic taste has subsided but fever of 100.2+headache but down to 99.4 with no headache 1 hour later.